Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS)

CNY 32.54

(-1.39%)

Market Cap (In CNY)

5.7 Billion

Revenue (In CNY)

1.11 Billion

Net Income (In CNY)

226.57 Million

Avg. Volume

2.13 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
28.11-46.84
PE
22.76
EPS
1.43
Beta Value
0.077
ISIN
CNE100004397
CUSIP
-
CIK
-
Shares
175440908.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Mingxu Yuan
Employee Count
-
Website
https://www.eastonpharma.cn
Ipo Date
2020-09-02
Details
Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry , and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China.